It has been observed that cancer intrinsic PD-L1 accelerates the epithelial-mesenchymal transition (EMT) in ovarian cancer, melanoma, breast cancer, nasopharyngeal carcinoma, and lung cancer [173, 177, 179, 186, 187]. Here, CD274 is linked to breast carcinoma.